Rock Springs Capital Management LP Aptinyx Inc. Transaction History

Rock Springs Capital Management LP

  • $2.94 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$3.99 - $19.33 $1.22 Million - $5.9 Million
-305,000 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$20.21 - $31.85 $707,350 - $1.11 Million
-35,000 Reduced 10.29%
305,000 $8.83 Million
Q2 2018

Aug 14, 2018
BUY
$19.83 - $24.17 $6.74 Million - $8.22 Million
340,000 New
340,000 $8.22 Million

About Aptinyx Inc.

APTX Quotes by TradingView
  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email